X4 Pharmaceuticals, Inc

By person

37 insiders · 126 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

GORDON CARL L

Director

$5.00M (1)

—

+$5.00M

1,868,966

$8.31M

—

MCGUIRE TERRANCE

Director

$5.00M (4)

—

+$5.00M

1,821,460

$8.10M

—

Polaris Venture Management Co. V, L.L.C. entity

10% owner

$5.00M (4)

—

+$5.00M

1,821,460

$8.10M

—

Ross Michael Jay

Director

$5.00M (2)

—

+$5.00M

1,868,961

$8.31M

—

SVLSF V, LLC entity

10% owner

$5.00M (2)

—

+$5.00M

1,868,961

$8.31M

—

NeoMed Innovation V L.P.

10% owner

$3.00M (1)

—

+$3.00M

867,639

$3.86M

—

Nessi Claudio

Director

$3.00M (1)

—

+$3.00M

867,639

$3.86M

—

Gerngross Tillman U.

Director

$2.00M (1)

—

+$2.00M

392,821

$1.75M

+283.1%

Ragan Paula

President and CEO

—

$1.25M (40)

−$1.25M

3,337,386

$14.83M

—

Mostafa Adam S.

Chief Financial Officer

—

$746.41K (21)

−$746.41K

850,000

$3.78M

—

EMBL Technology Fund II GmbH & Co. KG entity

10% owner

$200.00K (1)

—

+$200.00K

370,454

$1.65M

—

Meisner Derek M

Chief Legal Officer

—

$171.41K (8)

−$171.41K

145,155

$645.14K

—

DiBiase Mary

Chief Operating Officer

—

$143.94K (17)

−$143.94K

1,140,980

$5.07M

+1,777%

Stewart Murray

Director

—

$137.86K (1)

−$137.86K

7,883

$35.04K

—

Taveras Arthur

Chief Scientific Officer

—

$121.05K (6)

−$121.05K

388,026

$1.72M

—

KIRSKE DAVID

Chief Financial Officer

—

$109.25K (2)

−$109.25K

167,750

$745.56K

—

Volpone John

President

—

$109.23K (1)

−$109.23K

265,305

$1.18M

—

Skerlj Renato

Chief Scientific Officer

—

$46.96K (1)

−$46.96K

42,076

$187.01K

+38.4%

Craig Adam R

Executive Chairman

$250.00K (1)

$210.83K (1)

+$39.17K

328,651

$1.46M

—

WYZGA MICHAEL S

Director

$29.88K (1)

—

+$29.88K

5,555

$24.69K

—

Baldry Mark

Chief Commercial Officer

$21.81K (3)

$27.23K (3)

−$5.42K

25,337

$112.61K

—

Arbet-Engels Christophe

Chief Medical Officer

—

$5.28K (1)

−$5.28K

864,207

$3.84M

—

Cadavid Diego

Chief Medical Officer

—

— (1)

$0.00

104,107

$462.70K

—

ORBIMED ADVISORS LLC entity

10% owner

—

1,868,966

$8.31M

—

Bill & Melinda Gates Foundation entity

10% owner

—

722,179

$3.21M

—

Section 32 Fund 1, LP entity

10% owner

—

451,362

$2.01M

—

GV 2016 GP, L.L.C.

10% owner

—

451,362

$2.01M

—

GRAY MICHAEL

President, CEO and CFO

—

250,000

$1.11M

—

Alexandria Venture Investments, LLC entity

10% owner

—

225,680

$1.00M

—

Anna-Maria & Stephen Kellen Foundation, Inc. entity

10% owner

—

124,381

$552.81K

—

Lawton Alison Frances

Director

—

96,667

$429.64K

—

Aliski William

Director

—

96,667

$429.64K

—

Thoren Natasha Fay

Chief Legal Officer

—

9,462

$42.05K

+54.4%

Woods Keith

Director

—

6,000

$26.67K

—

MCGIRR DAVID W J

Director

—

4,722

$20.99K

—

Bridger Gary

Director

—

4,722

$20.99K

—

de Craecker Francoise

Director

—

4,722

$20.99K

—

No percentages here. This company's share count has moved by a factor of 15.2 over the window, from 11,408,357 to 173,662,376 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

By person

Individual transactions

What was left out